Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]

Mildred A Iro, Matthew D Snape, Merryn Voysey, Sena Jawad, Adam Finn, Paul T Heath, Gianni Bona, Susanna Esposito, Javier Diez-Domingo, Roman Prymula, Adefowope Odueyungbo, Daniela Toneatto, Peter Dull, Andrew J Pollard, European Men B Vaccine Study Group

Research output: Contribution to journalComment/debate (Academic Journal)peer-review

170 Downloads (Pure)

Abstract

[no abstract]
Original languageEnglish
Pages (from-to)3279
Number of pages1
JournalVaccine
Volume35
Issue number24
Early online date5 May 2017
DOIs
Publication statusPublished - 31 May 2017

Keywords

  • Published Erratum

Fingerprint

Dive into the research topics of 'Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]'. Together they form a unique fingerprint.

Cite this